Network with the Leading Companies in Pharma and Biotech on Topics Like
- Regulatory Requirements and Guidances
- Finding the Best Deployment Strategy
- Statistical Process Control as Part of CPV
- Signal Evaluation
- The Point of View of Quality by Design
Presenting Institutions and Companies
- Klaus Eichmueller, Wolnzach c/o Regional Council Darmstadt, GMP Inspectorate, Germany
- Dr Ajaz S. Hussain, Insight, Advice & Solutions, LLC, former FDA Deputy Director, USA
- Ajay Pazhayattil, Apotex Inc., Canada
- Nicolas Ballois, UCB BioPharma sprl, Belgium
- Dr Philip Hoersch, Vetter Pharma-Fertigung GmbH & Co. KG, Germany
- Dr Kai Juergens, Manufacturing, Bayer Pharma AG, Germany
- Dr Per Vase, NNE Pharmaplan, Denmark
- M. Narendira Kumar, Dr. Reddy’s Laboratories, India
- Gabriele Gold, Shire, Austria
- Stavros Politis PhD, Genepharm S.A., Greece
- Richard Falcon, Pfizer Biotech Ireland
- Jarle André Haugan PhD, GE Healthcare Life Sciences, Norway
- Robin Payne, BioPhorum, United Kingdom
- Dr Anja Keubler, AbbVie Deutschland GmbH & Co. KG, Germany
- Baptiste Berruée, Sanofi Pasteur – MTECH, France
Workshop Continuous Process Verification: Design, Structure, Continuous Improvement Robin Payne, BioPhorum, United Kingdom Dr Joerg Gampfer, Hovione, Portugal
